Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ELEVAI Labs Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ELAB
Nasdaq
8731
https://elevaiskincare.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ELEVAI Labs Inc
ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
- Apr 22nd, 2024 12:00 pm
Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results
- Mar 29th, 2024 4:00 pm
Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
- Mar 18th, 2024 12:30 pm
ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
- Jan 24th, 2024 1:30 pm
ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach
- Jan 17th, 2024 1:30 pm
ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology
- Jan 16th, 2024 1:30 pm
ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences
- Jan 2nd, 2024 2:15 pm
Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023
- Dec 11th, 2023 2:15 pm
ELEVAI Labs, Inc. Expands International Distribution into Europe
- Dec 7th, 2023 2:41 pm
Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products
- Nov 29th, 2023 2:00 pm
Univest Securities, LLC Announces Closing of $6 Million Initial Public Offering of Common Stock for its Client ELEVAI Labs Inc. (Nasdaq: ELAB)
- Nov 24th, 2023 5:00 pm
ELEVAI Labs, Inc. Announces Closing of $6,000,000 Initial Public Offering
- Nov 24th, 2023 4:15 pm
Scroll